These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 16879769

  • 1. Supportive care in multiple myeloma.
    Chanan-Khan A, Miller KC.
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):42-50. PubMed ID: 16879769
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Supportive care in multiple myeloma.
    Ludwig H, Zojer N.
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):817-35. PubMed ID: 18070721
    [Abstract] [Full Text] [Related]

  • 4. Treatment of multiple myeloma and acute myelogenous leukemia in the elderly: an update.
    Zagonel V, Babare R, Spazzapan S, Rupolo M, Bordonaro R, Ferrara F, Pinto A.
    Rays; 1997 Dec; 22(1 Suppl):30-6. PubMed ID: 9250011
    [Abstract] [Full Text] [Related]

  • 5. Clinical updates and nursing considerations for patients with multiple myeloma.
    Faiman B.
    Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Managing multiple myeloma in the elderly: are we making progress?
    Quach H, Prince HM, Spencer A.
    Expert Rev Hematol; 2011 Jun; 4(3):301-15. PubMed ID: 21668395
    [Abstract] [Full Text] [Related]

  • 9. Prognosis of asymptomatic multiple myeloma.
    Alexanian R, Barlogie B, Dixon D.
    Arch Intern Med; 1988 Sep; 148(9):1963-5. PubMed ID: 2458080
    [Abstract] [Full Text] [Related]

  • 10. Anemia and infections in multiple myeloma: supportive therapy.
    Cáceres W, Santiago K, Paulo L, Román J.
    Bol Asoc Med P R; 2009 Sep; 101(2):50-2. PubMed ID: 19954102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic approaches for newly diagnosed multiple myeloma patients in the era of novel drugs.
    Morabito F, Gentile M, Mazzone C, Bringhen S, Vigna E, Lucia E, Recchia AG, Raimondo FD, Musto P, Palumbo A.
    Eur J Haematol; 2010 Sep; 85(3):181-91. PubMed ID: 20491882
    [Abstract] [Full Text] [Related]

  • 14. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
    Lam A, Shah S, Paparello J.
    Am J Ther; 2008 Sep; 15(3):278-86. PubMed ID: 18496265
    [Abstract] [Full Text] [Related]

  • 15. Recent advances in the management of multiple myeloma.
    Kumar L, Verma R, Radhakrishnan VR.
    Natl Med J India; 2010 Sep; 23(4):210-8. PubMed ID: 21192514
    [Abstract] [Full Text] [Related]

  • 16. Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.
    Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P.
    Eur J Haematol; 2005 Oct; 75(4):293-8. PubMed ID: 16146535
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.
    Siegel DS, Vij R, Jakubowiak AJ.
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):1-15. PubMed ID: 21928467
    [Abstract] [Full Text] [Related]

  • 20. Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma.
    Katodritou E, Dimopoulos MA, Zervas K, Terpos E.
    Cancer Treat Rev; 2009 Dec; 35(8):738-43. PubMed ID: 19733008
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.